{"id":"sss11","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T05:30:35.030Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123024,"model":"claude-sonnet-4-5-20250929"},"description":"SSS11 is an investigational drug in Phase 1 clinical development by Shenyang Sunshine Pharmaceutical Co., LTD. The molecular target, mechanism of action, and therapeutic indication have not been publicly disclosed. As an early-stage candidate, safety and efficacy data are limited.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT06629376","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia","status":"RECRUITING","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","startDate":"2023-11-20","conditions":"Gout, Hyperuricemia","enrollment":60},{"nctId":"NCT04047394","phase":"PHASE1","title":"A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers","status":"UNKNOWN","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","startDate":"2019-10-22","conditions":"Gout","enrollment":33},{"nctId":"NCT03388515","phase":"PHASE1","title":"A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.","status":"UNKNOWN","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","startDate":"2017-10-09","conditions":"Gout","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["pegsiticase"],"phase":"phase_1","status":"active","brandName":"SSS11","genericName":"SSS11","companyName":"Shenyang Sunshine Pharmaceutical Co., LTD.","companyId":"shenyang-sunshine-pharmaceutical-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"SSS11 is a Pegylated Recombinant Candida Utilis Uricase for Injection being studied for its safety, tolerability, and pharmacokinetics in healthy adult volunteers. It is also being investigated for its potential to treat Gout and Hyperuricemia.","enrichmentLevel":2,"visitCount":2,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}